Atomic Golf Las Vegas is thrilled to announce their partnership with the American Cancer Society, beginning September 19. The ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Obermair calls for his fellow gynecological cancer surgeons to join him in interrogating current standards of practice.

The Senate Judiciary Committee is scheduled to mark up two bipartisan bills Thursday that affordable-drug proponents and generics makers say would make it easier for major pharma companies to game the ...

Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple ...

Karen Knudsen, PhD, CEO of both the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network, will transition from the organizations. Dr. Knudsen "will ...

Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...

1 American Cancer Society. Cancer Facts & Figures 2024 ... Actuate's lead investigational drug product, elraglusib (a novel GSK-3ß inhibitor), targets molecular pathways in cancer that are involved in ...

Leading GSK-3β Inhibitor with a Novel, Multimodal Mechanism of Action in Multiple Refractory Cancer TrialsOrphan Drug Designation in Soft Tissue Sarcomas Expands Company’s Potential to Address Cancers ...

With pivotal trial results and an approval from the FDA, the landscape is changing for patients with small cell lung cancer.

Researchers have uncovered a key reason why a typically normal protein goes awry and fuels cancer. They found the protein NSD2 alters the function of the androgen receptor, an important regulator of ...

Bispecific antibodies and anti-TIGIT therapies both appear to be writing comeback stories as cancer experts head to Barcelona for the 2024 European Society for Medical Oncology Congress. Radioligand ...